ConductScience.org, home

Paper41005308

Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens.

Zhou RW and 10 others. Cell, 2025. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. Papers, record 41005308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41005308

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens.
PubMed
Journal
Cell
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
3.27, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou RWRaymond W
2Purohit PKParesh Kumar
3Kim JHJai Hyun
4Lee SUSung-Uk
5Burshteyn NNicole
6Tifrea DDelia
7Cordon AAndres
8Grigorian AAni
9Newton BLBarbara L
10Edwards RARobert A
11Demetriou MMichael

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, Tumor-Associated, CarbohydrateMajor topic
ImmunotherapyMajor topic
NeoplasmsMajor topic
Animals
Humans
Mice
Polysaccharides
Tumor Microenvironment
T-Lymphocytes
Cell Line, Tumor
Female
Immunosuppression Therapy
Lectins

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
UM1 TR004927NCATS NIH HHSUnited StatesUM1TR004927PubMedNIH RePORTER
U01 CA233078NCI NIH HHSUnited StatesU01CA233078PubMed and NIHNIH RePORTER
R41 CA233111NCI NIH HHSUnited StatesR41CA233111PubMed and NIHNIH RePORTER
TL1 TR001875NCATS NIH HHSUnited StatesTL1TR001875PubMed and NIHNIH RePORTER
P30 CA062203NCI NIH HHSUnited StatesP30CA062203PubMed and NIHNIH RePORTER
UL1 TR001873NCATS NIH HHSUnited StatesUL1TR001873PubMedNIH RePORTER
R42 CA285234NCI NIH HHSUnited StatesR42CA285234PubMed and NIHNIH RePORTER
R41 CA261408NCI NIH HHSUnited StatesR41CA261408PubMed and NIHNIH RePORTER

Download CSV of grants

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114184143THE TREATMENT OF APLASTIC ANAEMIA WITH PHYTOHAEMAGGLUTININ.Lancet1964https://conductscience.org/library/papers/14184143PubMed
223054969Stratification of antibody-positive subjects by antibody level reveals an impact of immunogenicity on pharmacokinetics.AAPS J2013https://conductscience.org/library/papers/23054969PubMed
315879151Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.J Immunol2005https://conductscience.org/library/papers/15879151PubMed
424046919An update on the GLOB blood group system and collection.Immunohematology2013https://conductscience.org/library/papers/24046919PubMed
522531918Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.Eur J Immunol2012https://conductscience.org/library/papers/22531918PubMed
634484225Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models.Front Immunol2021https://conductscience.org/library/papers/34484225PubMed
715837749Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma.Clin Cancer Res2005https://conductscience.org/library/papers/15837749PubMed
822143985Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.Glycobiology2012https://conductscience.org/library/papers/22143985PubMed
916998493Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45.Nat Immunol2006https://conductscience.org/library/papers/16998493PubMed
1029045792Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.J Med Chem2017https://conductscience.org/library/papers/29045792PubMed
1125324212Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin.Chemistry2014https://conductscience.org/library/papers/25324212PubMed
1213955674In vivo action of phytohaemagglutinin in severe human aplastic anemia.Nature1963https://conductscience.org/library/papers/13955674PubMed
135168456The effects of intravenous phytohaemagglutinin in a patient with disseminated malignant melanoma: a clinical and immunological study.Rev Eur Etud Clin Biol1971https://conductscience.org/library/papers/5168456PubMed
14853039Biological and biochemical properties of Phaseolus vulgaris isolectins.J Biol Chem1977https://conductscience.org/library/papers/853039PubMed
1515459394Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.Science2004https://conductscience.org/library/papers/15459394PubMed
1610700233Suppression of tumor growth and metastasis in Mgat5-deficient mice.Nat Med2000https://conductscience.org/library/papers/10700233PubMed
1726172302MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.Oncotarget2015https://conductscience.org/library/papers/26172302PubMed
1811918084Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis.Clin Exp Metastasis2002https://conductscience.org/library/papers/11918084PubMed
1914224054PHYTOHAEMAGGLUTININ IN APLASTIC ANAEMIA.Lancet1964https://conductscience.org/library/papers/14224054PubMed
2027269286Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis.Elife2016https://conductscience.org/library/papers/27269286PubMed

See all 72 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42964319A Modular Polysaccharide Platform With Tannic Acid-Driven van der Waals Lock-In for Programmable Protein Delivery.Smart Med2026https://conductscience.org/library/papers/42964319PubMed
42891405A lectin-directed antibody-recruiting molecule against Tn antigen for cancer immunotherapy.RSC Adv2026https://conductscience.org/library/papers/42891405PubMed
42840183The Five-Decade Journey of Small Cell Lung Cancer.Cancer Commun (Lond)2026https://conductscience.org/library/papers/42840183PubMed
42764979Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy.Mater Today Bio2026https://conductscience.org/library/papers/42764979PubMed
42562812Post-translational modifications in metabolic reprogramming: implications for metabolic therapy and immunotherapy in cancer.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42562812PubMed
42504977Using Synthetic Glycans to Investigate Anti-Glycan Antibodies and Explore Their Medical Potential.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/42504977PubMed
42465518Spatial Glyco-Codes Define Human Liver Pathology and Progression.bioRxiv2026https://conductscience.org/library/papers/42465518PubMed
42457945Immune implications and therapeutic opportunities of tumor glycosylation.Nat Cancer2026https://conductscience.org/library/papers/42457945PubMed
42193932The Organoid Decade: Leveraging 3D Patient-Derived Organoids to Bridge the Translational Gap in Triple-Negative Breast Cancer: A Systematic Review.Cells2026https://conductscience.org/library/papers/42193932PubMed
42045937DHX37 and tumor growth: a novel avenue for melanoma research.J Transl Med2026https://conductscience.org/library/papers/42045937PubMed
42032105Organoid: a promising solution to current challenges in cancer immunotherapy.NPJ Biomed Innov2025https://conductscience.org/library/papers/42032105PubMed
41696681From Lock-and-Key to Velcro: Glycan-Dependent T Cell Recruiter Redefines Cancer Cell Targeting With Density-Dependent Recognition.MedComm (2020)2026https://conductscience.org/library/papers/41696681PubMed
41486933Integrative perspectives on glycosylation networks in fungi and oomycetes.J Microbiol2025https://conductscience.org/library/papers/41486933PubMed
41478862Double trouble for the tumour glycocode.Nat Rev Cancer2026https://conductscience.org/library/papers/41478862PubMed
41152449Lectin-based bispecific targets tumour-associated glycans.Nat Rev Drug Discov2025https://conductscience.org/library/papers/41152449PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41005308

GET https://conductscience.org/api/papers/v1/41005308/references?page=2